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1. General experimental details 
 
All batch reactions were performed using oven-dried glassware (200 °C) under an 
atmosphere of argon unless otherwise stated. All flow reactions were performed using a 
Uniqsis FlowSyn platform
1
 or a Vapourtec R2+R4 system.
2
 Solvents were freshly distilled 
over sodium benzophenone ketyl (THF) or calcium hydride (CH2Cl2, hexane and EtOAc). All 
reagents were obtained from commercial sources and used without further purification.  
 
Flash column chromatography was performed using high-purity grade silica gel (Merck grade 
9385) with a pore size 60 Å and 230–400 mesh particle size under air pressure. Analytical 
thin layer chromatography (TLC) was performed using silica gel 60 F254 pre-coated glass 
backed plates and visualized by ultraviolet radiation (254 nm) and/or potassium 
permanganate solution as appropriate.  
 
1
H NMR spectra were recorded on a 600 MHz Avance 600 BBI Spectrometer as indicated. 
Chemical shifts are reported in ppm with the resonance resulting from incomplete deuteration 
of the solvent as the internal standard (CDCl3: 7.26 ppm). 
13
C NMR spectra were recorded 
the same spectrometer with complete proton decoupling. Chemical shifts are reported in ppm 
with the solvent resonance as the internal standard (
13
CDCl3: 77.16 ppm, t). 
19
F NMR spectra 
were recorded on a 376 MHz Avance III HD Spectrometer. Chemical shifts are reported in 
ppm with CFCl3 as the external standard (CFCl3: 0.00 ppm). Data are reported as follows: 
chemical shift δ/ppm, integration (1H only), multiplicity (s = singlet, d = doublet, t = triplet, q 
= quartet, qn = quintet, br = broad, m = multiplet or combinations thereof; 
13
C signals are 
singlets unless otherwise stated), coupling constants J in Hz, assignment. Spectra are 
assigned as fully as possible, using 
1
H-COSY, DEPT-135, HMQC and HMBC where 
appropriate to facilitate structural determination. Signals that cannot be unambiguously 
assigned are reported with all possible assignments separated by a slash (e.g. H1/H2) or 
descriptions of their environments (e.g. ArH, OH). Multiple signals arising from diastereotopic 
or (pseudo)axial/equatorial positions are suffixed alphabetically (e.g. H1a, H1b). Overlapping 
signals that cannot be resolved are reported with their assignments denoted in list format (e.g. 
H1, H2 and H3). 
1
H NMR signals are reported to 2 decimal places and 
13
C signals to 1 
decimal place unless rounding would produce a value identical to another signal. In this case, 
an additional decimal place is reported for both signals concerned.  
 
Infrared spectra were recorded neat as thin films on a Perkin-Elmer Spectrum One FTIR 
spectrometer and selected peaks are reported (s = strong, m = medium, w = weak, br = broad). 
 
High resolution mass spectrometry (HRMS) was performed using positive electrospray 
ionisation (ESI+), on either a Waters Micromass LCT Premier spectrometer or performed by 
the Mass Spectrometry Service for the Chemistry Department at the University of Cambridge. 











2. Synthetic procedures and characterisation for homoallylic alcohols 
 
2.1. Homoallylic alcohol synthesis in flow 
 
General flow procedure for homoallylic alcohol synthesis: A solution of the vinyl boronic 
acid 2 (0.04 M, in CH2Cl2 : THF, 4:1 v/v) and a solution of TMSCHN2 (1) and aldehyde 3 
(0.066 M and 0.033 M, respectively, in CH2Cl2) were pumped (flow rate 0.4 mL min
-1
 each 
channel) and combined at a T-piece before reacting in a 20 mL perfluoroalkoxy alkanes (PFA) 
reactor coil (o.d. 1/16″,  = 25 min), at 60 °C. The exiting stream of borylated intermediate 
was then collected in a flask containing PS-tosyl hydrazine and MeOH (2 mL), and stirred 
overnight. The solvent was removed under reduced and the residue passed through a plug of 




Isolated as a colourless oil (82.6 mg, 0.260 mmol, 91%) after silica gel column 
chromatography (eluent: 10% → 15% EtOAc/hexane), following the general batch procedure 
for homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.33 (d, J = 8.4 Hz, 2 H, H2), 7.04 (d, J = 7.9 Hz, 2 H, H11), 
7.02 (d, J = 8.4 Hz, 2 H, H3), 6.93 (d, J = 7.9 Hz, 2 H, H10), 6.20 (ddd, J = 17.3, 10.2, 8.4 Hz, 
1 H, H7), 5.26 (d, J = 10.2 Hz, 1 H, H8cis), 5.22 (d, J = 17.1 Hz, 1 H, H8trans), 4.78 (dd, J = 
7.8, 2.0 Hz, 1 H, H5), 3.45 (t, J = 8.4 Hz, 1 H, H6), 2.37 (d, J = 2.0 Hz, 1 H, OH), 2.29 (s, 3 
H, H13). 
13
C NMR (150 MHz, CDCl3): δ 141.0 (C1), 137.8 (C7), 137.2 (C9), 136.5 (C12), 131.1 (C2), 





): 3440 (br w, OH), 3023 (w), 2919 (w), 1637 (w, C=C), 1593 (w), 1513 
(m), 1487 (m), 1407 (w), 1307 (w), 1188 (w), 1104 (w), 1070 (m), 1041 (m), 1010 (s), 920 
(m), 819 (s), 777 (w). 
HRMS (ESI): calculated for C17H18BrO [M+H]
+
 317.0536, found 317.0538.  















1-(4-bromophenyl)-2-(4-fluorophenyl)but-3-en-1-ol (4b):  
 
Isolated as a colourless oil (67.1 mg, 0.209 mmol, 73%) after silica gel column 
chromatography (eluent: 10% → 15% EtOAc/hexane), following the general flow procedure 
for homoallylic alcohol synthesis. Collection at steady state over 340 min for scale up 
provided 1.14 g of material (73%). 
 
1
H NMR (600 MHz, CDCl3): δ 7.33 (d, J = 8.4 Hz, 2 H, H2), 6.98 (m, 4 H, H3 and H10), 
6.91 (t, J = 8.7 Hz, 2 H, H11), 6.18 (ddd, J = 17.1, 10.2, 8.1, 1 H, H7), 5.29 (dd, J = 10.2, 0.5 
Hz, 1 H, H8cis), 5.23 (d, J = 17.1 Hz, 1 H, H8trans), 4.74 (dd, J = 8.1, 2.0 Hz, 1 H, H5), 3.47 (t, 
J = 8.1 Hz, 1 H, H6), 2.38 (d, J = 2.0 Hz, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 161.7 (d, J = 245.3 Hz, C12), 140.8 (C1), 137.5 (C7), 136.0 
(d, J = 3.2 Hz, C9), 131.2 (C2), 129.9 (d, J = 7.9 Hz, C10), 128.5 (C3), 121.5 (C4), 119.0 
(C8), 115.4 (d, J = 21.2 Hz, C11), 76.8 (d, J = 1.1 Hz, C5), 58.5 (C6). 
19
F NMR (376 MHz, CDCl3): δ -115.8 (s, 1 F, F12). 
FTIR (νmax, cm
-1
): 3420 (w, OH), 3076 (w), 2890 (w), 1637 (w, C=C), 1603 (w), 1508 (s), 
1488 (m), 1407 (w), 1306 (w), 1222 (s), 1160 (m), 1095 (w), 1070 (m), 1042 (w), 1010 (s), 
923 (w), 860 (w), 824 (s). 
HRMS (ESI): calculated for C16H13BrF [M+H-H2O]
+
 303.0179, found 303.0193.  





Isolated as a colourless oil (75.6 mg, 0.204 mmol, 71%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general flow procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.48 (d, J = 8.1 Hz, 2 H, H11), 7.35 (d, J = 8.4 Hz, 2 H, H2), 
7.17 (d, J = 8.1 Hz, 2 H, H10), 7.01 (d, J = 8.4 Hz, 2 H, H3), 6.20 (ddd, J = 17.1, 10.2, 9.0 Hz, 
1 H, H7), 5.31 (d, J = 10.2 Hz, 1 H, H8cis), 5.23 (d, J = 17.1 Hz, 1 H, H8trans), 4.82 (d, J = 7.5 
Hz, 1 H, H5), 3.59 – 3.54 (m, 1 H, H6), 2.32 (br d, J = 1.6 Hz, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 144.5 (q, J = 0.9 Hz, C9), 140.6 (C1), 136.7 (C7), 131.4 
(C2), 129.2 (q, J = 32.4 Hz, C12), 128.8 (C10), 128.4 (C3), 125.5 (q, J = 3.8 Hz, C11), 124.2 
(q, J = 272.0 Hz, C13), 121.7 (C4), 119.7 (C8), 76.6 (C5), 59.0 (C6). 
19




): 3420 (br w, OH), 2922 (w), 1618 (w, C=C), 1592 (w), 1487 (w), 1413 
(w), 1384 (w), 1324 (s), 1163 (m), 1122 (s), 1068 (s), 1010 (m), 925 (w), 821 (w), 767 (w). 
6 
 
HRMS (ESI): calculated for C17H13BrF3 [M+H-H2O]
+
 353.0147, found 353.0150.  




Isolated as a brown oil (74.5 mg, 0.254 mmol, 89%) after silica gel column chromatography 




H NMR (600 MHz, CDCl3): δ 8.31 (dd, J = 4.8, 1.3 Hz, 1 H, H1), 8.25 (d, J = 1.7 Hz, 1 H, 
H5), 7.50 – 7.45 (m, 3 H, H3 and H12), 7.18 (d, J = 8.1 Hz, 2 H, H11), 7.13 (dd, J = 7.8, 4.8 
Hz, 1 H, H2), 6.21 (ddd, J = 17.1, 10.3, 8.8 Hz, 1 H, H8), 5.29 (d, J = 10.3 Hz, 1 H, H9cis), 
5.18 (d, J = 17.1 Hz, 1 H, H9trans), 4.88 (d, J = 7.3 Hz, 1 H, H6), 3.65 (br s, 1 H, OH), 3.61 – 
3.56 (m, 1 H, H7). 
13
C NMR (150 MHz, CDCl3): δ 148.7 (C1), 148.1 (C5), 144.4 (q, J = 1.0 Hz, C10), 137.5 
(C4), 136.3 (C8), 134.4 (C3), 131.0, 129.1 (q, J = 32.4 Hz, C13), 128.7 (C11), 125.4 (q, J = 
3.7 Hz, C12), 124.0 (d, J = 272.0 Hz, C14), 123.1 (C2), 119.5 (C9), 74.7 (C6), 58.6 (C7). 
19




): 3164 (br w, OH), 1617 (w, C=C), 1581 (w), 1509 (w), 1426 (w), 1325 (s), 
1164 (w), 1122 (m), 1068 (m), 1018 (w), 924 (w), 831 (w). 
HRMS (ESI): calculated for C16H15F3NO [M+H]
+
 294.1100, found 294.1104.  




Isolated as a brown solid (39.0 mg, 0.160 mmol, 56%) after silica gel column 
chromatography (eluent: 80% EtOAc/hexane → EtOAc), following the general flow 
procedure for homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 8.34 (dd, J = 4.8, 1.8 Hz, 1 H, H1), 8.24 (d, J = 1.8 Hz, 1 H, 
H5), 7.47 (dt, J = 7.8, 1.8 Hz, 1 H, H3), 7.13 (dd, J = 7.8, 4.8 Hz, 1 H, H2), 6.99 (dd, J = 8.6, 
5.4 Hz, 2 H, H11), 6.90 (t, J = 8.6 Hz, 2 H, H12), 6.20 (ddd, J = 17.1, 10.2, 8.3 Hz, 1 H, H8), 
5.29 (dd, J = 10.2, 0.7 Hz, 1 H, H9cis), 5.21 (d, J = 17.1 Hz, 1 H, H9trans), 4.81 (d, J = 8.3 Hz, 
1 H, H6), 3.50 (t, J = 8.3 Hz, 1 H, H7), 3.31 (br s, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 161.8 (d, J = 245.6 Hz, C13), 148.7 (C1), 148.4 (C5), 137.6 
(C4), 137.2 (C8), 135.9 (d, J = 3.3 Hz, C10), 134.5 (C3), 129.9 (d, J = 7.9 Hz, C11), 123.1 
(C2), 119.1 (C9), 115.5 (d, J = 21.2 Hz, C12), 75.2 (C6), 58.4 (C7). 
19






): 3176 (br w, OH), 1638 (w, C=C), 1601 (w), 1507 (s), 1427 (w), 1222 (m), 
1160 (w), 1043 (w), 1029 (w), 922 (w), 829 (w). 
HRMS (ESI): calculated for C15H15FNO [M+H]
+
 244.1132, found 244.1129.  




Isolated as a yellow oil (52.8 mg, 0.206 mmol, 72%) after silica gel column chromatography 




H NMR (600 MHz, CDCl3): δ 7.56 (d, J = 8.2 Hz, 2 H, H10), 7.33 (d, J = 8.2 Hz, 2 H, H9), 
6.13 (ddd, J = 17.1, 10.2, 8.7 Hz, 1 H, H6), 5.60 (dqd, J = 15.3, 6.5, 0.9 Hz, 1 H, H2), 5.37 
(ddq, J = 15.3, 7.1, 1.5 Hz, 1 H, H3), 5.26 (d, J = 10.3 Hz, 1 H, H7cis), 5.19 (d, J = 17.1 Hz, 1 
H, H7trans), 4.31 – 4.27 (m, 1 H, H4), 3.44 – 3.40 (m, 1 H, H5), 1.86 (br s, 1 H, OH), 1.61 
(ddd, J = 6.5, 1.5, 0.5 Hz, 3 H, H1). 
13
C NMR (150 MHz, CDCl3): δ 145.4 (q, J = 1.1 Hz, C8), 137.3 (C6), 131.1 (C3), 129.0 (q, 
J = 32.4 Hz, C11), 129.0 (C9), 128.9 (C2), 125.4 (q, J = 3.8 Hz, C10), 124.4 (q, J = 271.8 Hz, 
C12), 118.6 (C7), 75.3 (C4), 57.0 (C5), 17.8 (C1). 
19




): 3420 (br w, OH), 2919 (w), 1618 (w, C=C), 1326 (s), 1164 (m), 1124 (m), 
1069 (m), 1019 (w), 966 (w), 923 (w), 834 (w). 
HRMS (ESI): calculated for C14H14F3O [M+H-H2]
+
 255.0991, found 255.1004.  




Isolated as a yellow oil (52.5 mg, 0.240 mmol, 84%) after silica gel column chromatography 




H NMR (600 MHz, CDCl3): δ 7.12 (d, J = 8.7 Hz, 2 H, H9), 6.85 (d, J = 8.7 Hz, 2 H, H10), 
6.11 (ddd, J = 17.1, 10.2, 8.8 Hz, 1 H, H6), 5.59 (dqd, J = 15.3, 6.5, 0.9 Hz, 1 H, H2), 5.39 
(ddq, J = 15.3, 6.8, 1.6 Hz, 1 H, H3), 5.21 (dd, J = 10.2, 1.1 Hz, 1 H, H7cis), 5.17 (d, J = 17.1 
Hz, 1 H, H7trans), 4.25 – 4.21 (m, 1 H, H4), 3.79 (s, 3 H, H12), 3.32 – 3.28 (m, 1 H, H5), 1.86 
(br s, 1 H, OH), 1.61 (ddd, J = 6.5, 1.6, 0.9 Hz, 3 H, H1). 
13
C NMR (150 MHz, CDCl3): δ 158.4 (C11), 138.5 (C6), 133.1 (C8), 131.5 (C3), 129.5 (C9), 





): 3425 (br w, OH), 2937 (w), 1611 (w, C=C), 1512 (s), 1465 (w), 1303 (w), 
1247 (s), 1179 (m), 1036 (m), 966 (w), 919 (w), 828 (w). 
HRMS (ESI): calculated for C14H17O [M+H-H2O]
+
 201.1274, found 201.1280.  




Isolated as a yellow oil (55.9 mg, 0.241 mmol, 84%) after silica gel column chromatography 




H NMR (600 MHz, CDCl3): δ 7.31 (dd, J = 1.8, 0.7 Hz, 1 H, H1), 7.09 (dd, J = 8.7, 5.4 Hz, 
2 H, H10), 6.92 (t, J = 8.7 Hz, 2 H, H11), 6.21 (dd, J = 3.2, 1.8 Hz, 1 H, H2), 6.18 (ddd, J = 
17.1, 10.3, 8.2 Hz, 1 H, H7), 6.05 (d, J = 3.2 Hz, 1 H, H3), 5.28 (d, J = 10.3 Hz, 1 H, H8cis), 
5.23 (d, J = 17.1 Hz, 1 H, H8trans), 4.84 (d, J = 8.2 Hz, 1 H, H5), 3.83 (t, J = 8.2 Hz, 1 H, H6), 
2.27 (br s, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 161.8 (d, J = 245.0 Hz, C12), 154.1 (C4), 142.0 (C1), 137.6 
(C7), 136.2 (d, J = 3.3 Hz, C9), 129.7 (d, J = 7.9 Hz, C10), 118.7 (C8), 115.4 (d, J = 21.2 Hz, 
C11), 110.2 (C2), 107.8 (C3), 71.1 (C5), 55.1 (C6). 
19




): 3435 (br w, OH), 1603 (w, C=C), 1509 (s), 1412 (w), 1223 (m), 1160 (w), 
1149 (w), 1011 (w), 920 (w), 884 (w), 859 (w), 832 (w). 
HRMS (ESI): calculated for C14H12FO2 [M+H-H2]
+
 231.0816, found 231.0822.  




Isolated as a colourless oil (73.4 mg, 0.222 mmol, 78%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following a modified general flow procedure 




H NMR (600 MHz, CDCl3): δ 7.55 (dd, J = 8.2, 1.0 Hz, 2 H, H17), 7.46 (d, J = 8.2 Hz, 2 H, 
H13), 7.42 (t, J = 7.7 Hz, 2 H, H18), 7.33 (t, J = 7.4 Hz, 1 H, H19), 7.25 – 7.21 (m, 3 H, H1 
and H14), 7.19 (td, J = 8.1, 1.7 Hz, 1 H, H3), 6.88 (td, J = 8.1, 0.7 Hz, 1 H, H2), 6.79 (d, J = 
8.1 Hz, 1 H, H4), 6.34 (ddd, J = 17.2, 10.2, 8.6 Hz, 1 H, H10), 5.23 (dd, J = 10.2, 1.1 Hz, 1 H, 
9 
 
H11cis), 5.20 (t, J = 6.0 Hz, 1 H, H8), 5.13 (d, J = 17.2 Hz, 1 H, H11trans), 3.83 – 3.78 (m, 1 H, 
H9), 3.74 (s, 3 H, H6), 2.68 (d, J = 6.0 Hz, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 156.5 (C5), 141.1 (C12/C16), 141.0 (C12/C16), 139.3 
(C15), 137.9 (C10), 130.3 (C7), 128.9 (C14/C18), 128.8 (C14/C18), 128.4 (C3), 128.1 (C1), 
127.2 (C19), 127.1 (C17), 126.9 (C13), 120.6 (C2), 117.8 (C11), 110.4 (C4), 73.8 (C8), 56.5 
(C9), 55.3 (C6). 
FTIR (νmax, cm
-1
): 3526 (br w, OH), 2960 (w), 2837 (w), 1602 (m, C=C), 1488 (w), 1460 
(w), 1438 (w), 1239 (w), 1205 (m), 1151 (s), 1067 (m), 1008 (w), 918 (w), 821 (w), 755 (w). 
HRMS (ESI): calculated for C23H21O2 [M+H-H2]
+
 329.1536, found 329.1542.  




Isolated as a colourless oil (39.0 mg, 0.201 mmol, 70%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general flow procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.30 – 7.26 (m, 1 H, H11), 7.00 (d, J = 7.7 Hz, 1 H, H8), 
6.96 – 6.89 (m, 2 H, H10 and H12), 6.09 (ddd, J = 17.1, 10.2, 9.1 Hz, 1 H, H5), 5.25 (dd, J = 
10.2, 1.2 Hz, 1 H, H6cis), 5.21 (d, J = 17.1 Hz, 1 H, H6trans), 3.74 – 3.69 (m, 1 H, H3), 3.29 – 
3.25 (m, 1 H, H4), 1.75 (br d, J = 3.2 Hz, 1 H, OH), 1.48 – 1.41 (m, 1 H, H2a), 1.37 – 1.29 (m, 
1 H, H2b), 0.94 (t, J = 7.4 Hz, 3 H, H1). 
13
C NMR (150 MHz, CDCl3): δ 163.1 (d, J = 246.0 Hz, C9), 144.5 (d, J = 6.9 Hz, C7), 
137.8 (C5), 130.2 (d, J = 8.3 Hz, C11), 123.8 (d, J = 2.8 Hz, C12), 118.5 (C6), 115.1 (d, J = 
21.4 Hz, C8), 113.7 (d, J = 21.0 Hz, C10), 75.3 (C3), 56.7 (d, J = 1.5 Hz, C4), 27.5 (C2), 10.1 
(C1). 
19




): 3447 (br w, OH), 2937 (m), 1614 (m, C=C), 1588 (s), 1489 (s), 1448 (m), 
1261 (m), 1151 (w), 965 (w), 921 (w), 782 (m). 
HRMS (ESI): calculated for C12H16FO [M+H]
+
 195.1180, found 195.1182.  




Isolated as a colourless oil (37.8 mg, 0.185 mmol, 65%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general flow procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.32 (t, J = 7.5 Hz, 2 H, H11), 7.23 (t, J = 7.5 Hz, 1 H, H12), 
7.20 (d, J = 7.5 Hz, 2 H, H10), 6.12 (ddd, J = 17.1, 10.1, 9.0 Hz, 1 H, H7), 5.25 – 5.17 (m, 2 
10 
 
H, H8cis and H8trans), 3.90 – 3.85 (m, 1 H, H5), 3.21 (dd, J = 9.0, 7.3 Hz, 1 H, H6), 1.86 – 
1.76 (m, 1 H, H3), 1.74 (dd, J = 3.4, 0.8 Hz, 1 H, OH), 1.33 (ddd, J = 14.1, 9.8, 4.5 Hz, 1 H, 
H4a), 1.12 – 1.06 (m, 1 H, H4b), 0.87 (d, J = 6.7 Hz, 3 H, H1/H2), 0.84 (d, J = 6.6 Hz, 3 H, 
H1/H2). 
13
C NMR (150 MHz, CDCl3): δ 141.9 (C9), 138.5 (C7), 128.8 (C11), 128.2 (C10), 126.8 
(C12), 118.0 (C8), 72.1 (C5), 58.1 (C6), 43.8 (C4), 24.7 (C3), 23.8 (C1/C2), 21.7 (C1/C2). 
FTIR (νmax, cm
-1
): 3436 (br w, OH), 2956 (m), 2929 (w), 2869 (w), 1602 (w, C=C), 1493 
(w), 1468 (w), 1453 (w), 1367 (w), 1151 (w), 1063 (w), 918 (w), 843 (w), 759 (w). 
HRMS (ESI): calculated for C14H19 [M+H-H2O]
+
 187.1481, found 187.1490.  
Rf = 0.39 (15% EtOAc/hexane). 
 
(4-fluorophenyl)-6-methylhept-1-en-4-ol (4l):  
 
Isolated as a colourless oil (28.1 mg, 0.126 mmol, 44%) after silica gel column 
chromatography (eluent: 10% EtOAc/hexane), following the general flow procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.17 (dd, J = 8.7, 5.4 Hz, 2 H, H10), 7.01 (t, J = 8.7 Hz, 2 H, 
H11), 6.08 (ddd, J = 17.1, 10.2, 9.1 Hz, 1 H, H7), 5.23 (dd, J = 10.2, 1.4 Hz, 1 H, H8cis), 5.18 
(d, J = 17.1 Hz, 1 H, H8trans), 3.86 – 3.80 (td, J = 7.0, 3.5 Hz, 1 H, H5), 3.20 (dd, J = 8.5, 7.4 
Hz, 1 H, H6), 1.85 – 1.75 (m, 1 H, H3), 1.72 (br d, J = 2.5 Hz, 1 H, OH), 1.31 (ddd, J = 14.0, 
9.8, 4.5 Hz, 1 H, H4a), 1.07 (ddd, J = 14.0, 9.6, 2.9 Hz, 1 H, H4b), 0.87 (d, J = 6.7 Hz, 3 H, 
H1/H2), 0.84 (d, J = 6.6 Hz, 3 H, H1/H2). 
13
C NMR (150 MHz, CDCl3): δ 161.7 (d, J = 244.8 Hz, C12), 138.3 (C7), 137.6 (d, J = 3.2 
Hz, C9), 129.6 (d, J = 7.8 Hz, C10), 118.2 (C8), 115.6 (d, J = 21.1 Hz, C11), 72.1 (C5), 57.1 
(C6), 43.9 (C4), 24.7 (C3), 23.8 (C1/C2), 21.7 (C1/C2). 
19




): 3426 (br w, OH), 2957 (m), 1603 (w, C=C), 1509 (s), 1468 (w), 1368 (w), 
1224 (m), 1160 (w), 1063 (w), 920 (w), 831 (w). 
HRMS (ESI): calculated for C14H20FO [M+H]
+
 223.1493, found 223.1499.  
Rf = 0.26 (10% EtOAc/hexane). 
 
(E)-3-(4-fluorophenyl)-6,10-dimethylundeca-1,5,9-trien-4-ol (4m-E, geranial-derived) 
and (Z)-3-(4-fluorophenyl)-6,10-dimethylundeca-1,5,9-trien-4-ol (4m-Z, neral-derived): 
    
(N.B. Using citral as the aldehyde component, 2:1 mixture of geranial and neral). Isolated as 
separable E/Z isomers as colourless oils (E-isomer: 53.7 mg, 0.186 mmol; Z-isomer: 26.2 mg, 
11 
 
0.091 mmol; combined yield 97%, E/Z ratio 2:1) after silica gel column chromatography 





H NMR (600 MHz, CDCl3): δ 7.16 (dd, J = 8.7, 5.5 Hz, 2 H, H15), 6.97 (t, J = 8.7 Hz, 2 H, 
H16), 6.14 (ddd, J = 17.1, 10.2, 8.8 Hz, 1 H, H12), 5.24 (dd, J = 10.2, 1.0 Hz, 1 H, H13cis), 
5.21 (d, J = 17.1 Hz, 1 H, H13trans), 5.09 (dd, J = 8.9, 1.0 Hz, 1 H, H9), 4.99 – 4.94 (m, 1 H, 
H4), 4.53 – 4.48 (m, 1 H, H10), 3.35 – 3.30 (m, 1 H, H11), 2.05 – 1.88 (m, 4 H, H5 and H6), 
1.74 (br s, 1 H, OH), 1.66 (s, 3 H, H1/H3), 1.57 (s, 3 H, H1/H3), 1.47 (d, J = 1.0 Hz, 3 H, H8). 
13
C NMR (150 MHz, CDCl3): δ 161.7 (d, J = 244.6 Hz, C17), 140.1 (C7), 138.2 (C12), 
136.8 (d, J = 3.2 Hz, C14)), 131.7 (C2), 130.0 (d, J = 7.8 Hz, C15), 125.1 (C9), 124.0 (C4), 
118.0 (C13), 115.2 (d, J = 21.1 Hz, C16), 71.1 (C10), 56.8 (C11), 39.7 (C6), 26.4 (C5), 25.8 
(C1/C3), 17.8 (C1/C3), 16.8 (C8). 
19




): 3447 (br w, OH), 2918 (m), 1638 (w), 1603 (w, C=C), 1509 (s), 1448 (w), 
1378 (w), 1223 (m), 1159 (w), 1096 (w), 1001 (w), 918 (w), 861 (w), 829 (m). 
HRMS (ESI): calculated for C19H24FO [M+H-H2]
+
 287.1806, found 287.1808.  




H NMR (600 MHz, CDCl3): δ 7.17 (dd, J = 8.7, 5.5 Hz, 2 H, H15), 6.97 (t, J = 8.7 Hz, 2 H, 
H16), 6.15 (ddd, J = 17.1, 10.3, 8.8 Hz, 1 H, H12), 5.23 (dd, J = 10.3, 1.2 Hz, 1 H, H13cis), 
5.18 (d, J = 17.1 Hz, 1 H, H13trans), 5.14 (d, J = 9.1 Hz, 1 H, H9), 5.05 (t, J = 6.8 Hz, 1 H, 
H4), 4.53 – 4.47 (m, 1 H, H10), 3.35 – 3.29 (m, 1 H, H11), 2.05 – 1.96 (m, 2 H, H5a and H6a), 
1.96 – 1.90 (m, 1 H, H6b), 1.90 – 1.80 (m, 1 H, H5b), 1.69 (s, 3 H, H1/H3), 1.66 (br d, J = 1.7 
Hz, 1 H, OH), 1.64 (d, J = 1.3 Hz, 3 H, H8), 1.58 (s, 3 H, H1/H3). 
13
C NMR (150 MHz, CDCl3): δ 161.7 (d, J = 244.6 Hz, C17), 140.4 (C7), 138.1 (C12), 
137.1 (d, J = 3.2 Hz, C14), 132.4 (C2), 129.9 (d, J = 7.8 Hz, C15), 126.1 (C9), 124.0 (C4), 
117.9 (C13), 115.3 (d, J = 21.1 Hz, C16), 70.6 (C10), 56.4 (C11), 32.4 (C6), 26.5 (C5), 25.8 
(C1/C3), 23.4 (C8), 17.8 (C1/C3). 
19




): 3447 (br w, OH), 2967 (w), 2914 (w), 1637 (w), 1603 (w, C=C), 1508 (s), 
1448 (w), 1377 (w), 1222 (m), 1159 (w), 1094 (w), 996 (w), 919 (w), 859 (w), 829 (m). 
HRMS (ESI): calculated for C19H24FO [M+H-H2]
+
 287.1806, found 287.1809.  






2.2. Homoallylic alcohol synthesis in batch 
 
General batch procedure for homoallylic alcohol synthesis: 
 
To a solution of aldehyde (0.3 mmol, 1.0 equiv.) and vinylboronic acid (0.36 mmol, 1.2 
equiv.) in CH2Cl2/THF (4:1, 3 mL) was added (trimethylsilyl)diazomethane (0.3 mL, 2 M in 
hexanes, 0.6 mmol, 2.0 equiv.) and the mixture subsequently stirred for 2 h. The mixture was 
quenched with SiO2 and stirred for a further 10 min, filtered and evaporated under reduced 
pressure. The residue was purified by silica gel column chromatography to provide the 




Isolated as a colourless oil (67.8 mg, 0.214 mmol, 71%) after silica gel column 
chromatography (eluent: 10% → 15% EtOAc/hexane), following the general batch procedure 
for homoallylic alcohol synthesis. Spectral data consistent with results from flow procedure. 
 
1-(4-bromophenyl)-2-(4-fluorophenyl)but-3-en-1-ol (4b):  
 
Isolated as a colourless oil (70.3 mg, 0.219 mmol, 73%) after silica gel column 
chromatography (eluent: 10% → 15% EtOAc/hexane), following the general batch procedure 




Isolated as a colourless oil (65.2 mg, 0.237 mmol, 79%) after silica gel column 
chromatography (eluent: 10% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.47 (d, J = 8.3 Hz, 2 H, H2), 7.23 (d, J = 8.3 Hz, 2 H, H3), 
5.83 (ddd, J = 17.3, 10.4, 8.7 Hz, 1 H, H7), 5.28 (dd, J = 10.4, 0.5 Hz, 1 H, H8cis), 5.16 (dd, J 
= 17.3, 0.5 Hz, 1 H, H8trans), 4.87 (d, J = 5.9 Hz, 1 H, H5), 3.62 (dd, J = 11.0, 6.2 Hz, 1 H, 
H9a), 3.38 (dd, J = 11.0, 5.5 Hz, 1 H, H9b), 2.63 – 2.57 (m, 1 H, H6), 2.19 (br s, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 140.9 (C1), 134.4 (C7), 131.6 (C2), 128.2 (C3), 121.8 (C4), 





): 3438 (w, OH), 2961 (w), 1676 (w), 1639 (w, C=C), 1591 (w), 1488 (m), 
1406 (w), 1293 (w), 1191 (w), 1071 (s), 1010 (s), 925 (m), 866 (w), 825 (s), 776 (w). 
HRMS (ESI): calculated for C11H11BrClO [M+H-H2]
+
 272.9676, found 272.9680.  




Isolated as a colourless oil (63.5 mg, 0.224 mmol, 75%) after silica gel column 
chromatography (eluent: 10% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.46 (d, J = 8.3 Hz, 2 H, H2), 7.19 (d, J = 8.3 Hz, 2 H, H3), 
5.62 (ddd, J = 17.2, 10.2, 9.3 Hz, 1 H, H7), 5.25 (dd, J = 10.2, 1.8 Hz, 1 H, H8cis), 5.17 (ddd, 
J = 17.2, 1.8, 0.6 Hz, 1 H, H8trans), 4.35 (dd, J = 7.7, 1.2 Hz, 1 H, H5), 2.27 – 2.16 (m, 2 H, 
H6 and H9a), 1.30 – 1.04 (m, 6 H, H9b, H10, H11 and OH), 0.80 (t, J = 7.1 Hz, 3 H, H12). 
13
C NMR (150 MHz, CDCl3): δ 141.7 (C1), 139.1 (C7), 131.4 (C2), 128.8 (C3), 121.5 (C4), 
119.3 (C8), 76.1 (C5), 52.9 (C6), 30.2 (C9), 29.5 (C10), 22.6 (C11), 14.1 (C12). 
FTIR (νmax, cm
-1
): 3430 (w, OH), 2956 (m), 2930 (m), 2858 (m), 1639 (w, C=C), 1593 (w), 
1487 (m), 1466 (w), 1405 (w), 1379 (w), 1307 (w), 1190 (w), 1121 (w), 1070 (m), 1041 (m), 
1010 (s), 915 (m), 821 (s). 
HRMS (ESI): calculated for C14H18BrO [M+H-H2]
+
 281.0536, found 281.0541.  




Isolated as a colourless oil (69.7 mg, 0.220 mmol, 73%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.48 (d, J = 8.4 Hz, 2 H, H2), 7.27 (t, J = 7.3 Hz, 2 H, H12), 
7.22 – 7.17 (m, 3 H, H3 and H13), 7.10 (d, J = 7.3 Hz, 2 H, H11), 5.69 (ddd, J = 17.2, 10.3, 
8.4 Hz, 1 H, H7), 5.15 (dd, J = 10.3, 1.4 Hz, 1 H, H8cis), 4.98 (d, J = 17.2 Hz, 1 H, H8trans), 
4.50 (d, J = 5.8 Hz, 1 H, H5), 2.72 (dd, J = 12.7, 4.9 Hz, 1 H, H9a), 2.64 – 2.53 (m, 2 H, H6 
and H9b), 2.27 (br s, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 141.7 (C1), 139.8 (C10), 137.3 (C7), 131.4 (C2), 129.2 




): 3423 (w, OH), 3062 (w), 3027 (w), 2920 (w), 1638 (w, C=C), 1593 (w), 
1488 (m), 1455 (w), 1405 (w), 1308 (w), 1229 (w), 1192 (w), 1103 (w), 1071 (m), 1031 (w), 
1009 (s), 918 (m), 836 (m), 820 (m), 784 (w). 
HRMS (ESI): calculated for C17H16Br [M+H-H2O]
+
 299.0430, found 299.0437.  
14 
 
Rf = 0.43 (15% EtOAc/hexane). 
 
tert-butyl (2-(2-(4-fluorophenyl)-1-hydroxybut-3-en-1-yl)phenyl)carbamate (4q): 
 
Isolated as a colourless oil (77.2 mg, 0.216 mmol, 72%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.87 (br s, 1 H, NH), 7.78 (d, J = 7.5 Hz, 1 H, H8), 7.15 (t, J 
= 7.5 Hz, 1 H, H7), 6.91 (dd, J = 8.4, 5.5 Hz, 2 H, H15), 6.83 (t, J = 8.6 Hz, 2 H, H16), 6.76 
(t, J = 7.5 Hz, 1 H, H6), 6.64 (d, J = 7.5 Hz, 1 H, H5), 6.23 (dt, J = 17.1, 9.6 Hz, 1 H, H12), 
5.35 (d, J = 9.6 Hz, 1 H, H13cis), 5.31 (d, J = 17.1 Hz, 1 H, H13trans), 4.74 (d, J = 9.6 Hz, 1 H, 
H10), 3.76 (t, J = 9.6 Hz, 1 H, H11), 3.00 (br s, 1 H, OH), 1.54 (s, 9 H, H1). 
13
C NMR (150 MHz, CDCl3): δ 161.6 (d, J = 245.2 Hz, C17), 153.5 (C3), 137.7 (C12), 
137.0 (C4), 135.9 (d, J = 3.2 Hz, C14), 129.6 (d, J = 7.9 Hz, C15), 129.1 (two overlapping 
signals, C5 and C9), 128.4 (C7), 122.9 (C6), 122.3 (C8), 119.0 (C13), 115.3 (d, J = 21.2 Hz, 
C16), 80.3 (C2), 78.3 (C10), 55.6 (C11), 28.5 (C1). 
19
F NMR (376 MHz, CDCl3): δ -115.8 (s, 1 F, F17). 
FTIR (νmax, cm
-1
): 3358 (w, OH), 2980 (w), 1698 (m, C=O), 1637 (w, C=C), 1590 (m), 1508 
(s), 1479 (w), 1446 (m), 1393 (w), 1368 (m), 1302 (m), 1226 (s), 1156 (s), 1050 (m), 1024 
(m), 908 (m), 860 (w), 830 (m), 755 (m). 
HRMS (ESI): calculated for C21H25FNO3 [M+H]
+
 358.1813, found 358.1808.  




Isolated as a colourless oil (88.0 mg, 0.247 mmol, 82%) after silica gel column 
chromatography (eluent: 5% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.68 (d, J = 2.3 Hz, 1 H, H5), 7.30 (dd, J = 8.5, 2.3 Hz, 1 H, 
H3), 7.24 (dd, J = 8.6, 5.5 Hz, 2 H, H12), 7.13 (d, J = 8.5 Hz, 1 H, H2), 6.98 (t, J = 8.6 Hz, 2 
H, H13), 6.21 (ddd, J = 17.1, 10.3, 9.0 Hz, 1 H, H9), 5.27 – 5.24 (m, 1 H, H7), 5.22 (d, J = 
10.3 Hz, 1 H, H10cis), 5.00 (d, J = 17.1 Hz, 1 H, H10trans), 3.69 (dd, J = 9.0, 5.0 Hz, 1 H, H8), 




C NMR (150 MHz, CDCl3): δ 161.9 (d, J = 245.3 Hz, C14), 141.7 (C6), 136.6 (d, J = 3.2 
Hz, C11), 135.3 (C9), 131.7 (C5), 131.5 (C3), 131.0 (C1), 130.7 (C2), 129.8 (d, J = 7.9 Hz, 
C12), 120.7 (C4), 119.5 (C10), 115.4 (d, J = 21.2 Hz, C13), 73.4 (C7), 55.1 (C8). 
19
F NMR (376 MHz, CDCl3): δ -115.8 (s, 1 F, F14). 
FTIR (νmax, cm
-1
): 3455 (w, OH), 1637 (w, C=C), 1603 (w), 1508 (s), 1456 (m), 1390 (w), 
1222 (s), 1182 (w), 1159 (m), 1136 (w), 1085 (m), 1042 (s), 1016 (m), 995 (m), 908 (m), 858 
(m), 829 (s), 810 (s). 
HRMS (ESI): calculated for C16H14BrClFO [M+H]
+
 354.9895, found 354.9899.  




Isolated as a yellow oil (69.6 mg, 0.166 mmol, 62%) after silica gel column chromatography 




H NMR (600 MHz, CDCl3): δ 7.48 (two superimposed d, J = 8.0 Hz, 4 H, H6 and H15), 
7.29 (d, J = 3.7 Hz, 1 H, H3), 7.26 (d, J = 5.0 Hz, 1 H, H1), 7.21 (d, J = 8.0 Hz, 2 H, H14), 
7.14 (d, J = 8.0 Hz, 2 H, H7), 7.07 (dd, J = 5.0, 3.7 Hz, 1 H, H2), 6.24 (ddd, J = 17.1, 10.2, 
8.1 Hz, 1 H, H11), 5.32 (d, J = 10.2 Hz, 1 H, H12cis), 5.24 (d, J = 17.1 Hz, 1 H, H12trans), 4.87 
(d, J = 8.1 Hz, 1 H, H9), 3.64 (t, J = 8.1 Hz, 1 H, H10), 2.35 (br s, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 144.8 (C13), 144.0 (C4), 140.8 (C8), 137.0 (C11), 133.9 
(C5), 129.0 (q, J = 32.4 Hz, C16), 128.9 (C14), 128.1 (C2), 127.3 (C7), 125.7 (C6), 125.4 (q, 
J = 3.7 Hz, C15), 125.0 (C1), 124.3 (q, J = 272.0 Hz, C17), 123.2 (C3), 119.3 (C12), 76.9 
(C9), 58.9 (C10). 
19
F NMR (376 MHz, CDCl3): δ -62.4 (s, 3 F, F17). 
FTIR (νmax, cm
-1
): 3432 (w, OH), 1617 (w, C=C), 1537 (w), 1501 (w), 1414 (w), 1323 (s), 
1260 (w), 1162 (m), 1118 (s), 1067 (s), 1017 (m), 959 (w), 924 (w), 818 (s), 767 (w). 
HRMS (ESI): calculated for C21H18F3OS [M+H]
+
 375.1025, found 375.1021.  




Isolated as a colourless oil (77.5 mg, 0.225 mmol, 75%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general batch procedure for 





H NMR (600 MHz, CDCl3): δ 7.00 (d, J = 8.6 Hz, 2 H, H10), 6.75 (d, J = 8.6 Hz, 2 H, 
H11), 6.18 (dt, J = 17.2, 10.1 Hz, 1 H, H7), 5.33 (d, J = 17.2 Hz, 1 H, H8trans), 5.31 (d, J = 
10.1 Hz, 1 H, H8cis), 5.18 (dd, J = 10.1, 4.7 Hz, 1 H, H5), 3.85 – 3.80 (m, 1 H, H6), 3.74 (s, 3 
H, H13), 2.56 (d, J = 4.7 Hz, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 158.8 (C12), 144.9 (approx. d, J = 248.4 Hz, C2), 140.6 (dtt, 
J = 253.8, 13.0, 5.2 Hz, C1), 138.3 (C7), 137.4 (approx. d, J = 249.9 Hz, C3), 131.3 (C9), 
128.6 (C10), 118.8 (C8), 115.3 (approx. t, J = 15.2 Hz, C4), 114.3 (C11), 69.1 (C5), 55.6 
(C6), 55.3 (C13). 
19
F NMR (376 MHz, CDCl3): δ -142.2 (dd, J = 21.8, 7.6 Hz, 2 F, F3), -154.8 (t, J = 20.9 Hz, 
1 F, F1), -162.1 – -162.4 (m, 2 F, F2). 
FTIR (νmax, cm
-1
): 3449 (w, OH), 2939 (w), 2841 (w), 1654 (w, C=C), 1611 (w), 1585 (w), 
1521 (m), 1500 (s), 1467 (w), 1444 (w), 1418 (w), 1303 (w), 1245 (m), 1179 (m), 1143 (w), 
1120 (m), 1033 (m), 991 (s), 927 (m), 856 (w), 828 (m), 776 (w). 
HRMS (ESI): calculated for C17H12F5O2 [M+H-H2]
+
 343.0752, found 343.0752.  




Isolated as a yellow oil (49.7 mg, 0.203 mmol, 68%) after silica gel column chromatography 




H NMR (600 MHz, CDCl3): δ 7.32 (d, J = 1.8 Hz, 1 H, H1), 7.06 (d, J = 8.7 Hz, 2 H, H10), 
6.78 (d, J = 8.7 Hz, 2 H, H11), 6.23 – 6.16 (m, 2 H, H2 and H7), 6.06 (d, J = 3.2 Hz, 1 H, 
H3), 5.25 (d, J = 10.3 Hz, 1 H, H8cis), 5.23 (d, J = 17.1 Hz, 1 H, H8trans), 4.85 (d, J = 8.0 Hz, 
1 H, H5), 3.79 (t, J = 8.0 Hz, 1 H, H6), 3.75 (s, 3 H, H13), 2.34 (br s, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 158.4 (C12), 154.4 (C4), 141.9 (C1), 138.0 (C7), 132.5 (C9), 




): 3437 (w, OH), 2916 (w), 2837 (w), 1637 (w, C=C), 1611 (m), 1584 (w), 
1511 (s), 1465 (w), 1442 (w), 1414 (w), 1303 (w), 1245 (s), 1178 (m), 1149 (m), 1033 (m), 
1009 (m), 912 (m), 884 (w), 856 (w), 826 (m). 
HRMS (ESI): calculated for C15H15O3 [M+H-H2]
+
 243.1016, found 243.1026.  




Isolated as a colourless oil (56.9 mg, 0.228 mmol, 76%) after silica gel column 
chromatography (eluent: 30% EtOAc/hexane), following the general batch procedure for 





H NMR (600 MHz, CDCl3): δ 7.62 (d, J = 8.1 Hz, 2 H, H3), 7.45 (d, J = 8.1 Hz, 2 H, H4), 
7.42 (d, J = 7.4 Hz, 2 H, H11), 7.38 (t, J = 7.4 Hz, 2 H, H12), 7.33 (t, J = 7.4 Hz, 1 H, H13), 
5.44 (s, 1 H, H9a), 5.16 (s, 1 H, H9b), 4.76 (dd, J = 9.0, 4.2 Hz, 1 H, H6), 3.00 (dd, J = 14.2, 
4.2 Hz, 1 H, H7a), 2.80 (dd, J = 14.2, 9.0 Hz, 1 H, H7b), 2.20 (br s, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 149.2 (C5), 144.3 (C10), 139.8 (C8), 132.4 (C3), 128.8 




): 3422 (w, OH), 3055 (w), 2947 (w), 2228 (m, C≡N), 1627 (w, C=C), 1609 
(m), 1574 (w), 1495 (m), 1445 (m), 1408 (m), 1303 (w), 1201 (w), 1056 (m), 1017 (m), 951 
(w), 905 (m), 879 (w), 838 (s), 780 (s). 
HRMS (ESI): calculated for C17H16NO [M+H]
+
 250.1226, found 250.1236.  




Isolated as a yellow oil (53.2 mg, 0.214 mmol, 71%) after silica gel column chromatography 




H NMR (600 MHz, CDCl3): δ 7.48 – 7.45 (m, 2 H, ArH), 7.38 – 7.34 (m, 4 H, ArH), 7.30 
(m, 4 H, ArH), 5.48 (d, J = 1.1 Hz, 1 H, H10a), 5.30 (d, J = 1.1 Hz, 1 H, H10b), 4.68 (ddd, J = 
7.5, 5.9, 5.3 Hz, 1 H, H7), 3.08 (ddd, J = 14.2, 5.9, 0.9 Hz, 1 H, H8a), 3.03 (ddd, J = 14.2, 7.5, 
0.7 Hz, 1 H, H8b), 2.02 (d, J = 5.3 Hz, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 144.0 (C11), 140.4 (C9), 131.8 (C2/C3/C12/C13), 128.6 
(C2/C3/C12/C13), 128.5 (C1/C14), 128.4 (C2/C3/C12/C13), 127.9 (C1/C14), 126.5 
(C2/C3/C12/C13), 122.7 (C4), 116.5 (C10), 89.6 (C6), 85.5 (C5), 61.6 (C7), 44.1 (C8). 
FTIR (νmax, cm
-1
): 3374 (w, OH), 3057 (w), 1629 (w, C=C), 1599 (w), 1574 (w), 1490 (m), 
1443 (m), 1341 (w), 1029 (s), 982 (w), 904 (m), 779 (m), 756 (s).  
HRMS (ESI): calculated for C18H15O [M+H-H2]
+
 247.1117, found 247.1129.  




Isolated as an orange oil (57.3 mg, 0.179 mmol, 60%) after silica gel column chromatography 






H NMR (600 MHz, CDCl3): δ 8.39 (d, J = 7.7 Hz, 1 H, H5), 7.61 (d, J = 7.7 Hz, 1 H, H2), 
7.33 (t, J = 7.7 Hz, 1 H, H4), 7.25 (t, J = 7.7 Hz, 1 H, H3), 7.06 (appears as s, 4 H, H16 and 
H17), 7.04 (br s, 1 H, H8), 6.26 (ddd, J = 17.1, 10.3, 9.0 Hz, 1 H, H13), 5.26 (d, J = 10.3 Hz, 
1 H, H14cis), 5.19 (d, J = 17.1 Hz, 1 H, H14trans), 5.11 (d, J = 6.9 Hz, 1 H, H11), 3.86 – 3.80 
(m, 1 H, H12), 2.58 (br s, 1 H, OH), 2.42 (s, 3 H, H10), 2.29 (s, 3 H, H19). 
13
C NMR (150 MHz, CDCl3): δ 168.7 (C9), 138.0 (C15), 137.4 (C13), 136.5 (C18), 136.0 
(C1), 129.3 (C17), 128.7 (C6), 128.1 (C16), 125.3 (C4), 123.56 (C3), 123.55 (C7), 123.0 
(C8), 119.9 (C2), 118.5 (C14), 116.7 (C5), 71.4 (C11), 56.3 (C12), 23.9 (C10), 21.1 (C19). 
FTIR (νmax, cm
-1
): 3434 (w, OH), 2923 (w), 1705 (s, C=O), 1606 (w, C=C), 1570 (w), 1513 
(w), 1450 (s), 1382 (s), 1348 (s), 1329 (s), 1249 (s), 1219 (s), 1147 (w), 1123 (m), 1087 (w), 
1034 (m), 1020 (m), 935 (m), 845 (s), 813 (m). 
HRMS (ESI): calculated for C21H22NO2 [M+H]
+
 320.1645, found 320.1631.  




Isolated as an inseparable mixture of regioisomers (1:1) as a colourless oil (56.9 mg, 0.203 
mmol, 67%) after silica gel column chromatography (eluent: 5% EtOAc/hexane), following 
the general batch procedure for homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.13 (two superimposed d, J = 7.9 Hz, 2 H, H16), 7.11 – 
7.07 (m, 2 H, H15), 6.14 – 6.06 (m, 1 H, H12), 5.23 – 5.16 (m, 2 H, H13cis and H13trans), 5.09 
– 5.05 (m, 1 H, H4), 3.89 – 3.84 (m, 1 H, H10), 3.20 – 3.14 (m, 1 H, H11), 2.33 (two 
superimposed s, 3 H, H18), 1.97 – 1.83 (m, 2 H, H5), 1.77 (s, 1 H, OH), 1.71 – 1.63 (m, 1 H, 
H7), 1.68 and 1.66 (two s, 3 H, H1/H3), 1.58 (two superimposed s, 3 H, H1/H3), 1.42 – 1.35 
(m, 1 H, H6/H9), 1.31 – 1.08 (m, 2 H, H6/H9), 1.07 – 0.96 (m, 1 H, H6/H9), 0.88 and 0.83 
(two d, J = 6.6 Hz, 3 H, H8). 
13
C NMR (150 MHz, CDCl3): δ 138.9 and 138.5 (C12), 138.8 and 138.7 (C14), 136.3 (C17), 
131.26 and 131.24 (C2), 129.5 (C16), 127.9 (C15), 124.99 and 124.93 (C4), 117.9 and 117.8 
(C13), 72.1 and 71.6 (C10), 58.0 and 57.4 (C11), 42.0 and 41.9 (C6/C9), 38.2 and 36.0 
(C6/C9), 29.3 and 29.0 (C7), 25.88 and 25.87 (C1/C3), 25.7 and 25.3 (C5), 21.2 (C18), 20.6 
and 18.9 (C8), 17.8 (C1/C3). 
FTIR (νmax, cm
-1
): 3483 (br w, OH), 2923 (s), 1726 (w), 1637 (w, C=C), 1514 (m), 1457 (m), 
1377 (m), 1251 (w), 1112 (m), 1063 (m), 1022 (m), 993 (m), 916 (s), 840 (s), 812 (s), 781 
(w). 
HRMS (ESI): calculated for C20H31O [M+H]
+
 287.2369, found 287.2370.  






Isolated as a colourless oil (58.4 mg, 0.183 mmol, 61%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 7.26 (t, J = 7.5 Hz, 2 H, H16), 7.20 – 7.14 (m, 3 H, H15 and 
H17), 5.75 (ddd, J = 17.3, 10.3, 9.0 Hz, 2 H, H11), 5.11 (dd, J = 10.3, 1.8 Hz, 1 H, H12cis), 
4.98 (dd, J = 17.3, 1.1 Hz, 1 H, H12trans), 4.40 (t, J = 5.0 Hz, 1 H, H, H5), 3.59 (d, J = 11.0 
Hz, 2 H, H4a), 3.51 (m, 1 H, H9), 3.40 (d, J = 11.0 Hz, 2 H, H4b), 2.87 (dd, J = 13.6, 6.7 Hz, 
1 H, H13a), 2.67 (dd, J = 13.6, 8.3 Hz, 1 H, H13b), 2.40 – 2.32 (m, 1 H, H10), 1.69 – 1.58 (m, 
2 H, H6), 1.58 – 1.52 (m, 2 H, H7a and OH), 1.51 – 1.46 (m, 2 H, H8), 1.46 – 1.39 (m, 1 H, 
H7b), 1.18 (s, 3 H, H1/H2), 0.71 (s, 3 H, H1/H2). 
13
C NMR (150 MHz, CDCl3): δ 140.4 (C14), 137.6 (C11), 129.4 (C15), 128.3 (C16), 126.0 
(C17), 118.2 (C12), 102.2 (C5), 77.33 (C4, almost overlaps with CDCl3 peak), 72.5 (C9), 




): 3465 (w, OH), 3027 (w), 2952 (m), 2850 (m), 1734 (w), 1638 (w, C=C), 
1603 (w), 1496 (w), 1455 (m), 1394 (m), 1363 (w), 1311 (w), 1237 (w), 1176 (w), 1135 (s), 
1080 (m), 1015 (s), 972 (m), 913 (s), 837 (w), 791 (w). 
HRMS (ESI): calculated for C20H30O3Na [M+Na]
+
 341.2087, found 341.2081.  




Isolated as a yellow oil (49.3 mg, 0.186 mmol, 62%) after silica gel column chromatography 




H NMR (600 MHz, CDCl3): δ 7.32 – 7.27 (m, 4 H, H2 and H3), 7.25 – 7.21 (m, 1 H, H1), 
7.18 – 7.13 (m, 4 H, H12 and H13), 6.57 (dd, J = 15.9, 1.2 Hz, 1 H, H5), 6.21 (ddd, J = 17.1, 
10.3, 8.8 Hz, 1 H, H9), 6.13 (dd, J = 15.9, 6.1 Hz, 1 H, H6), 5.30 – 5.22 (m, 2 H, H10cis and 
H10trans), 4.51 (m, 1 H, H7), 3.49 – 3.43 (m, 1 H, H8), 2.34 (s, 3 H, H15), 2.05 (d, J = 3.6 Hz, 
1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 138.1 (C9), 137.6 (C11), 137.0 (C4), 136.5 (C14), 131.1 
(C5), 130.0 (C6), 129.4 (C13), 128.6 (C3), 128.4 (C12), 127.6 (C1), 126.6 (C2), 118.1 (C10), 





): 3420 (br w, OH), 3025 (w), 2923 (w), 1670 (w, C=C), 1637 (w, C=C), 
1600 (w), 1514 (m), 1495 (m), 1449 (m), 1381 (w), 1297 (w), 1112 (m), 1070 (m), 966 (s), 
919 (m), 812 (s), 781 (w). 
HRMS (ESI): calculated for C19H19O [M+H-H2]
+
 263.1430, found 263.1438.  
Rf = 0.36 (15% EtOAc/hexane). 
 
Methyl 4-(2-(chloromethyl)-1-hydroxybut-3-en-1-yl)benzoate (4ab): 
 
Isolated as a colourless oil (49.7 mg, 0.195 mmol, 66%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 8.01 (d, J = 8.3 Hz, 2 H, H4), 7.43 (d, J = 8.3 Hz, 2 H, H5), 
5.82 (ddd, J = 17.3, 10.4, 8.7 Hz, 1 H, H9), 5.25 (dd, J = 10.4, 1.0 Hz, 1 H, H10cis), 5.12 (d, J 
= 17.3 Hz, 1 H, H10trans), 5.01 (dd, J = 5.1, 3.7 Hz, 1 H, H7), 3.91 (s, 3 H, H1), 3.66 (dd, J = 
11.0, 6.6 Hz, 1 H, H11a), 3.41 (dd, J = 11.0, 5.5 Hz, 1 H, H11b), 2.69 – 2.62 (m, 1 H, H8), 
2.25 (d, J = 3.7 Hz, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 167.0 (C2), 147.2 (C6), 134.1 (C9), 129.8 (C4), 129.7 (C3), 
126.4 (C5), 120.6 (C10), 72.8 (C7), 53.6 (C8), 52.3 (C1), 45.5 (C11). 
FTIR (νmax, cm
-1
): 3468 (w, OH), 2955 (w), 1703 (m, C=O), 1611 (w, C=C), 1577 (w), 1437 
(m), 1418 (w), 1311 (m), 1277 (s), 1193 (w), 1178 (w), 1111 (m), 1076 (w), 1018 (w), 996 
(w), 966 (w), 924 (w), 860 (w), 824 (w), 775 (w), 755 (w). 
HRMS (ESI): calculated for C13H16ClO3 [M+H]
+
 255.0782, found 255.0790.  




Isolated as a colourless oil (66.7 mg, 0.276 mmol, 92%) after silica gel column 
chromatography (eluent: 40% Et2O/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1
H NMR (600 MHz, CDCl3): δ 8.22 (t, J = 1.5 Hz, 1 H, H2), 8.12 (dd, J = 7.9, 1.5 Hz, 1 H, 
H6), 7.68 (d, J = 7.9 Hz, 1 H, H4), 7.52 (t, J = 7.9 Hz, 1 H, H5), 5.81 (ddd, J = 17.3, 10.3, 8.9 
Hz, 1 H, H9), 5.25 (d, J = 10.4 Hz, 1 H, H10cis), 5.14 – 5.06 (m, 2 H, H7 and H10trans), 3.71 
(dd, J = 11.0, 7.1 Hz, 1 H, H11a), 3.45 (dd, J = 11.0, 5.3 Hz, 1 H, H11b), 2.71 – 2.61 (m, 1 H, 
H8), 2.40 (br s, 1 H, OH). 
13
C NMR (150 MHz, CDCl3): δ 148.4 (C1), 144.4 (C3), 133.4 (C9), 132.6 (C4), 129.4 (C5), 
122.8 (C6), 121.4 (C2), 121.1 (C10), 72.0 (C7), 53.5 (C8), 45.3 (C11). 
FTIR (νmax, cm
-1
): 3518 (w, OH), 3080 (w), 1638 (w, C=C), 1583 (w), 1526 (s, N=O), 1480 
(w), 1440 (w), 1422 (w), 1348 (s, N=O), 1313 (m), 1255 (w), 1204 (w), 1092 (w), 1067 (w), 
995 (w), 926 (m), 908 (m), 838 (w), 810 (m), 788 (w). 
HRMS (ESI): calculated for C11H13ClNO3 [M+H]
+
 242.0578, found 242.0580.  






Isolated as a white solid (88.0 mg, 0.249 mmol, 83%) after silica gel column chromatography 




H NMR (600 MHz, CDCl3): δ 8.06 (s, 1 H, H5), 7.82 (d, J = 9.2 Hz, 1 H, H9), 7.33 – 7.26 
(m, 3 H, H10 and H18), 7.24 (d, J = 7.0 Hz, 2 H, H17), 7.20 (t, J = 7.2 Hz, 1 H, H19), 6.98 (d, 
J = 2.7 Hz, 1 H, H3), 5.79 (ddd, J = 17.3, 10.4, 8.3 Hz, 1 H, H13), 5.08 (t, J = 3.7 Hz, 1 H, 
H11), 5.01 (dd, J = 10.4, 1.1 Hz, 1 H, H14cis), 4.74 (d, J = 17.3 Hz, 1 H, H14trans), 3.89 (s, 3 H, 
H1), 3.00 – 2.91 (m, 2 H, H15), 2.85 (qd, J = 8.3, 3.7 Hz, 1 H, H12), 2.70 (d, J = 3.7 Hz, 1 H, 
OH). 
13
C NMR (150 MHz, CDCl3): δ 158.2 (C2), 146.0 (C7), 142.8 (C8), 139.6 (C16), 135.92 
(C5/C13), 135.91 (C5/C13), 135.3 (C6), 129.4 (two overlapping signals, C9 and C17), 128.4 
(C18), 128.2 (C4), 126.3 (C19), 123.0 (C10), 119.0 (C14), 105.2 (C3), 70.9 (C11), 55.6 (C1), 
50.5 (C12), 38.2 (C15). 
FTIR (νmax, cm
-1
): 3364 (w, OH), 3065 (w), 3027 (w), 2915 (w), 1623 (m, C=C), 1591 (m), 
1496 (s), 1465 (w), 1455 (m), 1418 (w), 1380 (w), 1339 (m), 1295 (w), 1227 (s), 1165 (m), 
1125 (w), 1085 (w), 1049 (s), 1030 (s), 998 (w), 959 (w), 911 (s), 829 (s), 793 (w). 
HRMS (ESI): calculated for C21H21ClNO2 [M+H]
+
 354.1255, found 354.1267.  




Isolated as a white solid (62.6 mg, 0.194 mmol, 65%) after silica gel column chromatography 




H NMR (600 MHz, CDCl3): δ 8.11 (s, 1 H, H5), 7.88 (d, J = 9.2 Hz, 1 H, H9), 7.34 (dd, J = 
9.2, 2.8 Hz, 1 H, H10), 7.06 (d, J = 2.8 Hz, 1 H, H3), 5.71 (ddd, J = 17.3, 10.2, 9.0 Hz, 1 H, 
H13), 5.18 – 5.10 (m, 2 H, H11 and H14cis), 4.92 (dd, J = 17.3, 1.0 Hz, 1 H, H14trans), 3.91 (s, 
3 H, H1), 2.52 – 2.45 (m, 1 H, H12), 2.38 (d, J = 3.8 Hz, 1 H, OH), 1.62 – 1.52 (m, 1 H, 
H15a), 1.52 – 1.43 (m, 1 H, H15b), 1.40 – 1.33 (m, 1 H, H16a), 1.33 – 1.23 (m, 3 H, H16b and 
H17), 0.86 (t, J = 7.1 Hz, 3 H, H18). 
13
C NMR (150 MHz, CDCl3): δ 158.3 (C2), 146.6 (C7), 143.0 (C8), 137.3 (C13), 135.8 (C5), 
135.2 (C6), 129.6 (C9), 128.4 (C4), 123.1 (C10), 119.1 (C14), 105.3 (C3), 72.4 (C11), 55.7 
(C1), 50.6 (C12), 31.1 (C15), 29.7 (C16), 22.7 (C17), 14.1 (C18). 
FTIR (νmax, cm
-1
): 3359 (w, OH), 2957 (m), 2931 (m), 2858 (m), 1623 (m, C=C), 1591 (m), 
1497 (s), 1465 (w), 1420 (w), 1379 (w), 1338 (m), 1228 (s), 1166 (m), 1118 (w), 1046 (m), 
1001 (w), 959 (w), 917 (m), 830 (m). 
22 
 
HRMS (ESI): calculated for C18H23NO2Cl [M+H]
+
 320.1412, found 320.1411.  
Rf = 0.35 (40% EtOAc/hexane). 
 
Summary of Data CCDC 1483699 
Compound Name: Formula: C18 H22 Cl1 N1 O2 
Unit Cell Parameters: a 9.46790(10) b 11.3192(2) c 16.4547(3) P-1 




To a solution of 4n (43.5 mg, 0.156 mmol, 1 equiv.) in anhydrous CH2Cl2 (1 mL) at 0 °C was 
added DIPEA (0.06 mL, 0.312 mmol, 2 equiv.) then triethylsilyl trifluoromethanesulfonate 
(0.06 mL, 0.234 mmol, 1.5 equiv.). The mixture was warmed to r.t. and stirred for 15 min, 
then partitioned between EtOAc (15 mL) and sat. aq. NaHCO3 solution (15 mL). The organic 
layer was separated and the aqueous layer extracted further with EtOAc (3 × 10 mL). The 
combined organic extracts were dried (MgSO4) and evaporated under reduced pressure. The 
residue was purified by silica gel column chromatography (eluent: hexane) to provide the title 
product 5 (58.2 mg, 0.149 mmol, 95%) as a colourless oil. 
 
1
H NMR (600 MHz, CDCl3): δ 7.42 (d, J = 8.3 Hz, 2 H, H2), 7.16 (d, J = 8.3 Hz, 2 H, H3), 
5.74 (ddd, J = 17.4, 10.2, 9.0 Hz, 1 H, H10), 5.11 (dd, J = 10.4, 0.7 Hz, 1 H, H11cis), 4.98 (d, 
J = 3.7 Hz, 1 H, H5), 4.93 (dd, J = 17.3, 0.7 Hz, 1 H, H11trans), 3.70 (dd, J = 10.7, 7.7 Hz, 1 H, 
H9a), 3.37 (dd, J = 10.7, 5.8 Hz, 1 H, H9b), 2.52 – 2.45 (m, 1 H, H8), 0.89 (t, J = 8.0 Hz, 9 H, 
H7), 0.54 (q, J = 8.0 Hz, 6 H, H6). 
13
C NMR (150 MHz, CDCl3): δ 142.3 (C1), 134.3 (C10), 131.1 (C2), 128.3 (C3), 121.1 (C4), 





): 2956 (w), 2912 (w), 2877 (w), 1640 (w, C=C), 1592 (w), 1486 (m), 1458 
(w), 1406 (w), 1363 (w), 1294 (w), 1239 (w), 1201 (w), 1107 (m), 1085 (s), 1003 (s), 922 (m), 
872 (w), 826 (m), 788 (w). 
HRMS (ESI): calculated for C17H27BrClOSi [M+H]
+
 389.0698, found 389.0703.  





To a solution of 5 (55.8 mg, 0.143 mmol) in CH2Cl2/MeOH (9:1, 15 mL) was bubbled O3/O2 
at -78 °C until the reaction mixture turned blue (ca. 5-10 min). Argon was then bubbled 
through the solution until residual O3 had disappeared. Polymer-supported PPh3 (3 mmol/g 
loading, 144 mg, ca. 0.42 mmol) was then added and the mixture stirred at r.t. for 1 h. The 
polymer-supported reagent was then filtered off and the filtrate evaporated under reduced 
pressure to provide the crude aldehyde, which was used immediately without further 
purification.  
 
To a solution of the crude aldehyde and trans-2-(4-fluorophenyl)vinylboronic acid (35.7 mg, 
0.21 mmol, 1.5 equiv.) in CH2Cl2/THF (4:1, 1.5 mL) was added (trimethylsilyl)diazomethane 
(0.14 mL, 2 M in hexanes, 0.28 mmol, 2.0 equiv.) and the mixture subsequently stirred for 2 
h. The mixture was quenched with SiO2 and stirred for a further 10 min, filtered and 
evaporated under reduced pressure. The residue was purified by silica gel column 
chromatography (eluent: 5% EtOAc/hexane) to provide the title product 5a (57.6 mg, 0.140 
mmol, 98% over 2 steps) as a colourless viscous oil.  
 
1
H NMR (600 MHz, CDCl3): δ 7.45 (d, J = 8.3 Hz, 2 H, H2), 7.02 (d, J = 8.3 Hz, 2 H, H3), 
6.82 (t, J = 8.6 Hz, 2 H, H14), 6.62 (dd, J = 8.6, 5.4 Hz, 2 H, H13), 5.94 (ddd, J = 17.1, 10.3, 
7.8 Hz, 1 H, H16), 5.28 (s, 1 H, H5), 5.06 (d, J = 10.3 Hz, 1 H, H17cis), 4.96 (d, J = 17.1 Hz, 
1 H, H17trans), 3.99 (d, J = 10.3 Hz, 1 H, H10), 3.85 (dd, J = 11.5, 3.4 Hz, 1 H, H9a), 3.79 (t, J 
= 11.5 Hz, 1 H, H9b), 3.52 (s, 1 H), 3.31 (dd, J = 10.3, 7.8 Hz, 1 H, H11), 1.51 – 1.46 (m, 1 H, 
H8), 0.92 (t, J = 8.0 Hz, 9 H, H7), 0.61 (q, J = 8.0 Hz, 6 H, H6). 
13
C NMR (150 MHz, CDCl3): δ 161.6 (d, J = 245.4 Hz, C15), 141.5 (C1), 139.4 (C16), 
136.2 (d, J = 3.3 Hz, C12), 131.4 (C2), 129.1 (d, J = 7.8 Hz, C13), 127.5 (C3), 121.2 (C4), 
116.4 (C17), 115.7 (d, J = 21.2 Hz, C14), 74.0 (C5), 71.6 (C10), 53.2 (C11), 49.7 (C8), 41.9 
(C9), 6.9 (C7), 4.7 (C6). 
19
F NMR (376 MHz, CDCl3): δ -115.7 (s, 1 F, F15). 
FTIR (νmax, cm
-1
): 3509 (br w, OH), 2957 (w), 2878 (w), 1637 (w, C=C), 1604 (w), 1509 
(m), 1486 (w), 1458 (w), 1440 (w), 1224 (m), 1194 (w), 1159 (w), 1067 (s), 995 (s), 919 (m), 
828 (s), 799 (w). 
HRMS (ESI): calculated for C25H34BrClFO2Si [M+H]
+
 527.1179, found 527.1184.  







To a solution of 5a (102 mg, 0.193 mmol) in acetone/2,2-dimethoxypropane (4:1, 4 mL) was 
added (±)-camphorsulfonic acid (9.0 mg, 0.039 mmol). The mixture was stirred at r.t. for 16 
h. The reaction was then quenched with Et3N (4 drops) and the solvent removed under 
reduced pressure. The residue was purified by silica gel column chromatography (eluent: 5% 
EtOAc/hexane) to provide the title product 6 (79.8 mg, 0.176 mmol, 91%) as a white foam. 
 
1
H NMR (600 MHz, CDCl3): δ 7.46 (d, J = 8.4 Hz, 2 H, H2), 7.26 (d, J = 8.4 Hz, 2 H, H3), 
7.21 (dd, J = 8.6, 5.3 Hz, 2 H, H13), 7.04 (t, J = 8.6 Hz, 2 H, H14), 6.12 (ddd, J = 17.2, 10.3, 
6.2 Hz, 1 H, H16), 5.09 (d, J = 10.3 Hz, 1 H, H17cis), 4.89 (d, J = 6.9 Hz, 1 H, H5), 4.85 (d, J 
= 17.2 Hz, 1 H, H17trans), 4.44 (dd, J = 10.9, 4.5 Hz, 1 H, H10), 3.67 (dd, J = 11.6, 7.5 Hz, 1 
H, H9a), 3.61 (dd, J = 10.9, 6.2 Hz, 1 H, H11), 3.46 (dd, J = 11.6, 3.5 Hz, 1 H, H9b), 2.11 – 
2.06 (m, 1 H, H8), 1.54 (s, 3 H, H7a/H7b), 1.44 (s, 3 H, H7a/H7b). 
13
C NMR (150 MHz, CDCl3): δ 161.9 (d, J = 246.1 Hz, C15), 140.7 (C1), 139.7 (d, J = 0.9 
Hz, C16), 135.6 (d, J = 3.4 Hz, C12), 131.8 (C2), 129.7 (d, J = 7.9 Hz, C13), 129.0 (C3), 
121.9 (C4), 116.4 (C17), 116.1 (d, J = 21.3 Hz, C14), 101.9 (C6), 72.9 (C5), 71.0 (C10), 49.1 
(C11), 45.8 (C8), 42.7 (C9), 25.0 (C7a/C7b), 24.6 (C7a/C7b). 
19
F NMR (376 MHz, CDCl3): δ -115.0 (s, 1 F, F15). 
FTIR (νmax, cm
-1
): 2986 (w), 2936 (w), 1637 (w, C=C), 1604 (w), 1509 (s), 1489 (m), 1445 
(w), 1409 (w), 1380 (m), 1281 (w), 1220 (s), 1159 (s), 1092 (m), 1071 (m), 1053 (m), 1009 
(s), 910 (m), 889 (w), 832 (s), 804 (m), 774 (w). 
HRMS (ESI): calculated for C22H24BrClFO2 [M+H]
+
 453.0627, found 453.0616.  





To a solution of 6 (79.8 mg, 0.176 mmol) in CH2Cl2/MeOH (9:1, 15 mL) was bubbled O3/O2 
at -78 °C until the reaction mixture turned blue (ca. 5 min). Argon was then bubbled through 
the solution until residual O3 had disappeared. Polymer-supported PPh3 (3 mmol/g loading, 
175 mg, ca. 0.53 mmol) was then added and the mixture stirred at r.t. for 1 h. The polymer-
supported reagent was then filtered off and the filtrate evaporated under reduced pressure to 




To a solution of the crude aldehyde and trans-2-(4-methylphenyl)vinylboronic acid (43.7 mg, 
0.27 mmol, 1.5 equiv.) in CH2Cl2/THF (4:1, 2 mL) was added (trimethylsilyl)diazomethane 
(0.18 mL, 2 M in hexanes, 0.36 mmol, 2.0 equiv.) and the mixture subsequently stirred for 2 
h. The mixture was quenched with SiO2 and stirred for a further 10 min, filtered and 
evaporated under reduced pressure. The residue was purified by silica gel column 
chromatography (eluent: 10% EtOAc/hexane) to provide the title products 6a as separable 
diastereomers (major diastereomer: 63.7 mg, 0.108 mmol; minor diastereomer: 10.1 mg, 




H NMR (600 MHz, CDCl3): δ 7.44 (d, J = 8.4 Hz, 2 H, H2), 7.23 – 7.17 (m, 4 H, H3 and 
H13), 7.10 (d, J = 8.0 Hz, 2 H, H20), 7.09 – 7.04 (m, 4 H, H14 and H19), 6.30 (dt, J = 17.3, 
10.0 Hz, 1 H, H23), 5.24 (dd, J = 10.0, 1.4 Hz, 1 H, H24cis), 4.93 (d, J = 17.3 Hz, 1 H, 
H24trans), 4.90 (d, J = 6.1 Hz, 1 H, H5), 4.77 (dd, J = 11.0, 3.9 Hz, 1 H, H10), 4.11 (dd, J = 
7.2, 3.5 Hz, 1 H, H16), 4.07 (s, 1 H, OH), 3.74 (dd, J = 11.4, 8.5 Hz, 1 H, H9a), 3.52 (dd, J = 
11.4, 3.3 Hz, 1 H, H9b), 3.12 (dd, J = 10.0, 3.5 Hz, 1 H, H17), 3.07 (dd, J = 11.0, 7.2 Hz, 1 H, 
H11), 2.32 (s, 3 H, H22), 1.89 – 1.84 (m, 1 H, H8), 1.55 (s, 3 H, H7a/H7b), 1.50 (s, 3 H, 
H7a/H7b). 
13
C NMR (150 MHz, CDCl3): δ 162.1 (d, J = 247.0 Hz, C15), 140.5 (C1), 140.0 (C18), 
137.0 (C23), 136.0 (C21), 134.4 (d, J = 3.3 Hz, C12), 131.8 (C2), 130.2 – 129.8 (br, C13), 
129.2 (C20), 128.8 (C3), 128.1 (C19), 122.0 (C4), 118.2 (C24), 116.2 (d, J = 21.2 Hz, C14), 
102.1 (C6), 80.1 (C16), 73.1 (C5/C10), 73.0 (C5/C10), 52.7 (C17), 47.6 (C11), 45.1 (C8), 
42.6 (C9), 25.6 (C7a/C7b), 25.0 (C7a/C7b), 21.2 (C22). 
19
F NMR (376 MHz, CDCl3): δ -114.0 (s, 1 F, F15). 
FTIR (νmax, cm
-1
): 3487 (br w, OH), 2989 (w), 2939 (w), 1606 (w, C=C), 1509 (s), 1490 (w), 
1445 (w), 1409 (w), 1382 (m), 1223 (s), 1160 (m), 1113 (m), 1097 (m), 1054 (m), 1010 (m), 
973 (w), 910 (m), 835 (s), 812 (m). 
HRMS (ESI): calculated for C31H33BrClFO3Na [M+Na]
+
 609.1178, found 609.1165.  




H NMR (600 MHz, CDCl3): δ 7.41 (d, J = 8.3 Hz, 2 H, H2), 7.21 (d, J = 8.3 Hz, 2 H, H3), 
7.16 (d, J = 7.8 Hz, 2 H, H19), 6.98 (br s, 2 H, H14), 6.95 (d, J = 7.8 Hz, 2 H, H20), 5.87 (dt, 
J = 17.0, 10.0 Hz, 1 H, H23), 5.04 (d, J = 10.0 Hz, 1 H, H24cis), 4.97 (d, J = 17.0 Hz, 1 H, 
H24trans), 4.80 – 4.76 (m, 2 H, H5 and H10), 4.52 – 4.48 (m, 1 H, H16), 3.47 (dd, J = 11.3, 
8.6 Hz, 1 H, H9a), 3.20 (dd, J = 11.3, 3.3 Hz, 1 H, H9b), 2.78 (d, J = 11.5 Hz, 1 H, H11), 2.67 
(t, J = 10.0 Hz, 1 H, H17), 2.37 (s, 3 H, H22), 1.86 – 1.81 (m, 1 H, H8), 1.77 (d, J = 3.6 Hz, 1 
H, OH), 1.525 (s, 3 H, H7a/H7b), 1.517 (s, 3 H, H7a/H7b). (N.B. 2 H corresponding to H13 
appear broadened over 7.50 – 6.50 region). 
13
C NMR (150 MHz, CDCl3): δ 162.2 (d, J = 246.1 Hz, C15), 141.1 (C1), 140.7 (C23), 
137.3 (C18), 136.6 (C21), 131.7 (d, J = 3.4 Hz, C12), 131.7 (C2), 129.7 (C20), 129.1 (C3), 
128.2 (C19), 121.8 (C4), 117.3 (C24), 115.5 – 115.0 (br, C14), 101.9 (C6), 73.3 (C5), 70.0 
(C16), 68.1 (C10), 55.2 (C17), 45.9 (C11), 45.1 (C8), 43.0 (C9), 25.3 (C7a/C7b), 24.8 
(C7a/C7b), 21.3 (C22). (N.B. signal corresponding to C13 too broadened to distinguish 
accurately). 
19
F NMR (376 MHz, CDCl3): δ -114.9 (s, 1 F, F15). 
FTIR (νmax, cm
-1
): 3569 (br w, OH), 2990 (w), 2934 (w), 1606 (w, C=C), 1509 (s), 1490 (w), 
1445 (w), 1380 (m), 1286 (w), 1223 (s), 1161 (m), 1102 (w), 1070 (m), 1010 (m), 974 (w), 
910 (w), 845 (w), 812 (m), 784 (w). 
HRMS (ESI): calculated for C31H33BrClFO3Na [M+Na]
+
 609.1178, found 609.1167.  
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To a solution of 7 (44.1 mg, 0.075 mmol, 1 equiv.) in anhydrous CH2Cl2 (1 mL) at 0 °C was 
added DIPEA (0.04 mL, 0.150 mmol, 2 equiv.) then triethylsilyl trifluoromethanesulfonate 
(0.04 mL, 0.225 mmol, 1.5 equiv.). The mixture was warmed to r.t. and stirred for 30 min, 
then partitioned between EtOAc (15 mL) and sat. aq. NaHCO3 solution (15 mL). The organic 
layer was separated and the aqueous layer extracted further with EtOAc (3 × 10 mL). The 
combined organic extracts were dried (MgSO4) and evaporated under reduced pressure. The 
residue was purified by silica gel column chromatography (eluent: 5% EtOAc/hexane) to 
provide the title product 7 (50.8 mg, 0.072 mmol, 96%) as a white foam. 
 
1
H NMR (600 MHz, CDCl3): δ 7.46 (d, J = 8.4 Hz, 2 H, H2), 7.28 (d, J = 8.4 Hz, 2 H, H3), 
7.19 (d, J = 7.8 Hz, 2 H, H19), 7.11 (d, J = 7.8 Hz, 2 H, H20), 6.93 (t, J = 8.6 Hz, 2 H, H14), 
6.88 (br s, 2 H, H13), 5.97 (ddd, J = 16.8, 9.7, 9.4 Hz, 1 H, H23), 5.00 – 4.95 (m, 3 H, H10, 
H24cis and H24trans), 4.84 (d, J = 6.8 Hz, 1 H, H5), 4.07 (t, J = 9.4 Hz, 1 H, H17), 4.00 (d, J = 
9.4 Hz, 1 H, H16), 3.28 (dd, J = 11.5, 7.9 Hz, 1 H, H9a), 3.02 (dd, J = 11.5, 3.5 Hz, 1 H, H9b), 
2.93 (d, J = 11.4 Hz, 1 H, H11), 2.38 (s, 3 H, H22), 2.08 – 2.03 (m, 1 H, H8), 1.60 (s, 3 H, 
H7a/H7b), 1.59 (s, 3 H, H7a/H7b), 0.89 (t, J = 8.0 Hz, 9 H, H26), 0.50 (q, J = 8.0 Hz, 6 H, 
H25). 
13
C NMR (150 MHz, CDCl3): δ 161.7 (d, J = 245.8 Hz, C15), 141.3 (C1), 140.9 (C23), 
140.1 (C18), 137.0 – 136.8 (br, C12), 136.1 (C21), 131.7 (C2), 130.2 – 129.2 (br, C13), 129.5 
(C19), 129.0 (C3), 128.9 (C20), 121.8 (C4), 116.4 (C24), 115.6 (br d, J = 20.7 Hz, C14), 
101.7 (C6), 82.7 – 82.4 (br, C16), 73.1 (C5), 67.1 (C10), 56.1 (C17), 45.7 (C8), 45.8 – 45.5 
(br, C11), 43.0 (C9), 25.6 (C7a/C7b), 24.8 (C7a/C7b), 21.3 (C22), 7.2 (C26), 5.9 (C25). 
19
F NMR (376 MHz, CDCl3): δ -115.5 (s, 1 F, F15). 
FTIR (νmax, cm
-1
): 2953 (m), 2877 (m), 1607 (w, C=C), 1510 (s), 1490 (w), 1458 (w), 1411 
(w), 1380 (m), 1222 (s), 1160 (m), 1113 (s), 1089 (s), 1056 (m), 1010 (s), 975 (w), 911 (w), 
832 (w), 777 (w). 
HRMS (ESI): calculated for C37H46BrClFO2Si [M+H]
+
 701.2150, found 701.2129.  







To a solution of 7 (50.8 mg, 0.072 mmol) in CH2Cl2/MeOH (9:1, 15 mL) was bubbled O3/O2 
at -78 °C until the reaction mixture turned blue (ca. 3 min). Argon was then bubbled through 
the solution until residual O3 had disappeared. Polymer-supported PPh3 (3 mmol/g loading, 
72 mg, ca. 0.21 mmol) was then added and the mixture stirred at r.t. for 1 h. The polymer-
supported reagent was then filtered off and the filtrate evaporated under reduced pressure to 
provide the crude aldehyde, which was used immediately without further purification.  
 
To a solution of the crude aldehyde and trans-2-phenylvinylboronic acid (16.0 mg, 0.108 
mmol, 2 equiv.) in CH2Cl2/THF (4:1, 1 mL) was added (trimethylsilyl)diazomethane (0.07 
mL, 2 M in hexanes, 0.144 mmol, 2.0 equiv.) and the mixture subsequently stirred for 2 h. 
The mixture was quenched with SiO2 and stirred for a further 10 min, filtered and evaporated 
under reduced pressure. The residue was purified by silica gel column chromatography 
(eluent: 10% EtOAc/hexane) to provide the title product 8 (50.8 mg, 0.062 mmol, 86% over 2 
steps) as a white foam.  
 
1
H NMR (600 MHz, CDCl3): δ 7.42 (d, J = 8.4 Hz, 2 H, H2), 7.34 (t, J = 7.4 Hz, 2 H, H27), 
7.27 (t, J = 7.4 Hz, 1 H, H28), 7.20 (d, J = 8.4 Hz, 2 H, H3), 7.06 (d, J = 7.4 Hz, 2 H, H26), 
6.90 (t, J = 8.6 Hz, 2 H, H14), 6.78 (br s, 2 H, H13), 5.93 (dt, J = 17.0, 10.0 Hz, 1 H, H29), 
5.11 (dd, J = 10.1, 1.1 Hz, 1 H, H30cis), 5.05 (d, J = 17.0 Hz, 1 H, H30trans), 4.84 – 4.79 (m, 1 
H, H10), 4.63 (d, J = 6.9 Hz, 1 H, H5), 4.31 (d, J = 10.0 Hz, 1 H, H23), 4.18 (d, J = 10.7 Hz, 
1 H, H16), 3.30 (br d, J = 10.7 Hz, 1 H, H17), 3.08 (dd, J = 11.4, 8.2 Hz, 1 H, H9a), 2.85 (dd, 
J = 11.4, 3.5 Hz, 1 H, H9b), 2.80 (t, J = 10.0 Hz, 1 H, H24), 2.63 (d, J = 11.4 Hz, 1 H, H11), 
2.43 (s, 3 H, H22), 1.99 – 1.94 (m, 1 H, H8), 1.78 (s, 1 H, OH), 1.18 (s, 3 H, H7a/H7b), 1.05 
(s, 3 H, H7a/H7b), 0.95 (t, J = 8.0 Hz, 9 H, H32), 0.61 – 0.48 (m, 6 H, H31). (N.B. 4 H 
corresponding to H19/H20 appear broadened over 7.60 – 7.10 region). 
13
C NMR (150 MHz, CDCl3): δ 161.6 (d, J = 245.4 Hz, C15), 141.4 (C1), 141.2 (C25), 
140.5 (C29), 137.5 (br, C12), 136.3 (C18/C21), 136.2 (C18/C21), 131.7 (C2), 130.2 – 128.5 
(br, C13, C19 and C20), 129.1 (C3), 128.8 (C27), 128.6 (C26), 126.9 (C28), 121.7 (C4), 
118.0 (C30), 115.5 (br, C14), 101.5 (C6), 80.7 (C16), 73.1 (C5), 71.5 (C23), 66.8 (C10), 56.3 
(C24), 50.9 (C17), 45.7 (C8), 44.8 (br, C11), 43.0 (C9), 24.8 (C7a/C7b), 24.0 (C7a/C7b), 21.4 
(C22), 7.4 (C32), 5.7 (C31). 
19
F NMR (376 MHz, CDCl3): δ -115.8 (s, 1 F, F15). 
FTIR (νmax, cm
-1
): 3569 (w, OH), 2954 (w), 2876 (w), 1606 (w, C=C), 1510 (s), 1490 (m), 
1454 (w), 1417 (w), 1380 (m), 1222 (s), 1160 (m), 1102 (s), 1074 (s), 1056 (m), 1009 (s), 961 
(w), 908 (m), 833 (s), 803 (m), 778 (w). 
HRMS (ESI): calculated for C45H56BrClFO4Si [M+H]
+
 821.2798, found 821.2804.  











 iteration products: 
 




C shifts of the acetonide for the 2
nd
 iteration product 6 confirms a twist-
boat structure, indicating that the reaction proceeds through Felkin-Anh selectivity. 
 
 
Deprotection of the TES protecting group with TBAF allowed a spontaneous 6-ring 
cyclisation to the corresponding pyran. Analysis of the coupling constants once again 





To a solution of 7 (0.250 g, 0.356 mmol, 1 equiv.) in anhydrous THF (8.5 mL) at 0 °C was 
added a solution of TBAF (1.42 mL, 1.0 M in THF, 1.42 mmol, 4 equiv.). The mixture was 
then stirred at r.t. for 16 h. The mixture was diluted with brine (5 mL) and EtOAc (5 mL) and 
the organic layer separated. The aqueous layer was extracted further with EtOAc (3 × 5 mL) 
and the combined organic extracts dried (MgSO4) and evaporated under reduced pressure. 
The residue was purified by silica gel column chromatography (50% CH2Cl2/hexane) to 
provide the title product 9 (0.194 g, 0.352 mmol, 99%) as a white foam. 
 
1
H NMR (600 MHz, CDCl3): δ 7.51 (d, J = 8.4 Hz, 2 H, H2), 7.29 (br dd, J = 7.5, 5.8 Hz, 2 
H, H13), 7.24 (d, J = 8.4 Hz, 2 H, H3), 7.18 (d, J = 8.0 Hz, 2 H, H19), 7.13 (d, J = 8.0 Hz, 2 
H, H20), 7.06 (appears t, J = 8.7 Hz, 2 H, H14), 6.16 (dt, J = 17.2, 10.0 Hz, 1 H, H23), 5.16 
(dd, J = 10.0, 1.7 Hz, 1 H, H24cis), 4.84 (dd, J = 17.2, 1.7 Hz, 1 H, H24trans), 4.27 (d, J = 11.0 
Hz, 1 H, H16), 4.24 (d, J = 6.1 Hz, 1 H, H5), 4.17 (t, J = 3.1 Hz, 1 H, H10), 4.01 (dd, J = 
11.2, 5.9 Hz, 1 H, H9a), 3.93 (t, J = 11.2 Hz, 1 H, H9b), 3.09 (d, J = 9.6 Hz, 1 H, H17), 2.97 
(dd, J = 11.0, 3.1 Hz, 1 H, H11), 2.36 (s, 3 H, H22), 2.27 – 2.20 (m, 1 H, H8), 1.44 (s, 3 H, 
H7a/H7b), 1.09 (s, 3 H, H7a/H7b). 
13
C NMR (150 MHz, CDCl3): δ 161.9 (d, J = 244.6 Hz, C15), 141.5 (C1), 140.4 (C18), 
136.3 (C23), 135.9 (C21), 135.1 (d, J = 3.2 Hz, C12), 131.8 (C2), 131.3 (d, J = 7.6 Hz, C13), 
129.1 (C20), 128.0 (C19), 127.5 (C3), 121.5 (C4), 117.7 (C24), 114.9 (d, J = 20.9 Hz, C14), 
29 
 
101.5 (C6), 78.6 (C16), 71.6 (C5), 66.9 (C9), 66.7 (C10), 50.6 (C17), 47.5 (C11), 44.2 (C8), 
25.0 (C7a/C7b), 24.1 (C7a/C7b), 21.1 (C22). 
19
F NMR (376 MHz, CDCl3): δ -116.1 (s, 1 F, F15). 
FTIR (νmax, cm
-1
): 2985 (w), 2925 (w), 1636 (w, C=C), 1605 (w), 1510 (s), 1489 (m), 1456 
(w), 1379 (m), 1283 (w), 1219 (s), 1159 (m), 1135 (m), 1112 (m), 1096 (m), 1073 (m), 1058 
(m), 1004 (m), 982 (m), 957 (w), 941 (w), 908 (s), 857 (m), 830 (s), 790 (m). 
HRMS (ESI): calculated for C31H33BrFO3 [M+H]
+
 551.1592, found 551.1583.  











Ar = 4-Fluorophenyl 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3:  
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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(4-fluorophenyl)-6-methylhept-1-en-4-ol (4l):  
 
1
H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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tert-butyl (2-(2-(4-fluorophenyl)-1-hydroxybut-3-en-1-yl)phenyl)carbamate (4q): 
 
1
H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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Methyl 4-(2-(chloromethyl)-1-hydroxybut-3-en-1-yl)benzoate (4ab): 
 
1
H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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phenyl)-3-(p-tolyl)pent-4-en-2-ol (6a, major diastereomer): 
 
1
H NMR, 600 MHz, CDCl3: 
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phenyl)-3-(p-tolyl)pent-4-en-2-ol (6a, minor diastereomer): 
 
1
H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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H NMR, 600 MHz, CDCl3: 
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F NMR, 376 MHz, CDCl3: 
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